A new study led by Dr. Hilla Chen from the Koret School of Veterinary Medicine at Hebrew University, recently published in ...

High ionized calcium levels were associated with an increased risk for hyperparathyroidism, especially among men.

重组人甲状旁腺激素是一种人工合成的甲状旁腺激素，用于治疗甲状旁腺功能减退症（甲状旁腺功能低下）。重组人甲状旁腺激素用于治疗骨质疏松性骨折风险较高的绝经后妇女的骨质疏松症。研究表明，脊椎骨折的发生率显著降低。它与钙和维生素 D 补充剂 ...

Researchers in Israel have tested a potential treatment for chronic kidney disease (CKD) in dogs. The study, published in the ...

Barb Broome had a family doctor to help her navigate her changing calcium levels. Since her physician retired in November ...

How well do injection protocols affect the progression of osteoporosis in bone? A new study from a group of Swiss researchers has surprising answers. The study, titled “ Combining systemic and local ...

A phase 3 trial of AstraZeneca’s $800 million rare disease candidate has met its primary endpoint. The update keeps ...

UK-based AstraZeneca’s acquired rare disease drug has met the primary endpoint in a Phase III trial in patients with chronic ...

High-level results from the CALYPSO Phase III trial showed that eneboparatide (AZP-3601), an investigational parathyroid hormone (PTH) receptor 1 agonist, met its primary endpoint with statistical ...

AstraZeneca Plc (NASDAQ:AZN) released high-level results from the CALYPSO Phase 3 trial designed to evaluate the efficacy and ...